Ads
related to: list of preferred stocks wall street journal
Search results
1 Artificial Intelligence (AI) Stock to Buy Hand Over Fist, According to Wall Street
Motley Fool via Yahoo Finance· 6 days agoThe Wall Street Journal tracks 30 analysts covering Atlassian stock, and 13 have given it the...
Bill Ackman selling stake in Pershing Square at $10.5 billion valuation, aiming for IPO one day
CNBC· 5 days agoBillionaire investor Bill Ackman is selling a 10% stake in Pershing Square, aiming to eventually...
Bill Ackman’s Pershing Square Capital could go public soon
Quartz· 5 days agoActivist investor and newly-public persona Bill Ackman has IPO ambitions. The hedge-fund manager,...
The 10 Biggest Rounds Of May: xAI And CoreWeave Lead Big Month For AI
Crunchbase· 1 day agoThis is a monthly feature that runs down the month’s top 10 funding rounds in the U.S. Check out the...
Can Bill Ackman Cash In on His Growing Fame?
New York Times· 1 day agoThe billionaire investor’s profile has soared on social media. Bill Ackman has gained new prominence in recent months for his outspoken presence on...
OPEC+ Moves Set to Keep Oil Prices High - What’s News - WSJ Podcasts
The Wall Street Journal· 2 days agoPeter Granitz: OPEC+ agrees to keep in place its curbs to oil production. Expect prices to remain...
Signs of a Slowdown Are Becoming Hard to Ignore
Morningstar· 1 day agoAs evidence mounts that the economy is slowing, pressure to lower rates could build. The U.S. economy continues to lose momentum . Investors' attention on Friday was initially focused on the ...
EMEA Morning Briefing: Shares Could Head Lower Amid Rate Anxiety
Morningstar· 6 days agoMARKET WRAPS Watch For: Unemployment data for EU, Italy; EU business & consumer surveys; trading updates from Auto Trader, SAS Opening Call: Shares seem set to retreat in Europe on Thursday.
What’s Behind Elon Musk’s Bromance with Donald Trump
New York Times· 6 days agoThe Republican is courting the mogul to bolster his re-election fight, but the Biden campaign sees a political opportunity to exploit. For much of...
AstraZeneca started at buy at Goldman, which rates GSK a neutral
Morningstar· 6 days agoGoldman Sachs started coverage of AstraZeneca at buy as it rated rival pharmaceutical company GSK a neutral. Analysts led by Rajan Sharma said AstraZeneca is its preferred ...
